Tearful relations: Oxidative stress, inflammation and eye diseases;Relações lacrimejantes: Estresse oxidativo, inflamação e doenças oculares

Arquivos Brasileiros de Oftalmologia

Volumn 71, Issue 6 SUPP, 2009, Pages 72-79

  Wakamatsu, Tais Hitomi ^a   Dogru, Murat ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dry eye syndromes; Eye diseases; Oxidative stress; Tears enzymology

Indexed keywords

AGED; AGING; DRY EYE; ENVIRONMENT; HUMAN; KERATITIS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW;

AGED; AGING; DRY EYE SYNDROMES; ENVIRONMENT; HUMANS; KERATITIS; OXIDATIVE STRESS;

EID: 68949204935     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492008000700015     Document Type: Article

References (42)

1. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, Uchiyama S, et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A. 2006;103(30):11282-7.
2. Spector A. Oxidative stress-induced cataract: mechanism of action. Faseb J. 1995;9(12):1173-82.
3. Gritz DC, Montes C, Atalla LR, Wu GS, Sevanian A, Rao NA. Histochemical localization of superoxide production in experimental autoimmune uveitis. Curr Eye Res. 1991;10(10):927-31.
4. Niesman MR, Johnson KA, Penn JS. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res. 1997;22(5):597-605.
5. Alio JL, Ayala MJ, Mulet ME, Artola A, Ruiz JM, Bellot J. Antioxidant therapy in the treatment of experimental acute corneal inflammation. Ophthalmic Res. 1995;27(3):136-43.
6. Alio JL, Artola A, Serra A, Ayala MJ, Mulet ME. Effect of topical antioxidant therapy on experimental infectious keratitis. Cornea. 1995;14(2):175-9.
7. Valentine JS, Doucette PA, Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem. 2005;74:563-93.
8. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-208.
9. Drechsel DA, Patel M. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic Biol Med. 2008;44(11):1873-86.
10. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998;39(3):471-5.
11. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984;219(1):1-14.
12. Kontos HA. George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ Res. 1985;57(4):508-16.
13. Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K, et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci. 1999;40(1):28-34.
14. Iwata M, Kiritoshi A, Roat MI, Yagihashi A, Thoft RA. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma. Invest Ophthalmol Vis Sci. 1992;33(9):2714-21.
15. Mircheff AK, Gierow JP, Wood RL. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells. Invest Ophthalmol Vis Sci. 1994;35(11):3943-51.
16. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82(5):885-98.
17. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol. 1992;76(9):545-9.
18. Baudouin C, Brignole F, Becquet F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens Invest Ophthalmol Vis Sci. 1997;38(7):1458-64.
19. Nakamura S, Shibuya M, Nakashima H, Hisamura R, Masuda N, Imagawa T, et al. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci. 2007;48(4):1552-8.
20. Augustin AJ, Spitznas M, Kaviani N, Meller D, Koch FH, Grus F, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol. 1995;233(11):694-8.
21. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10(2): 248-53.
22. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52(4):601-23.
23. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 1996;274(5290):1194-7.
24. Kleiman NJ, Wang RR, Spector A. Ultraviolet light induced DNA damage and repair in bovine lens epithelial cells. Curr Eye Res. 1990;9(12):1185-93.
25. Shimmura S, Suematsu M, Shimoyama M, Tsubota K, Oguchi Y, Ishimura Y. Subthreshold UV radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin. Exp Eye Res. 1996;63 (5):519-26.
26. Forteza R. Casalino-Matsuda SM, Monzon ME, Fries E, Rugg MS, Milner CM, et al. TSG-6 potentiates the antitissue kallikrein activity of inter-inhibitor through bikunin release. Am J Respir Cell Mol Biol. 2007;36(1): 20-31.
27. Lima MF, Kierszenbaum F. Lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J Immunol. 1987;139(5):1647-51.
28. Dogru M, Matsumoto Y, Yamamoto Y, Goto E, Saiki M, Shimazaki J, et al. Lactoferrin in Sjogren's syndrome. Ophthalmology. 2007;114(12):2366-7.
29. Satici A, Bitiren M, Ozardali I, Vural H, Kilic A, Guzey M. The effects of chronic smoking on the ocular surface and tear characteristics: a clinical, histological and biochemical study. Acta Ophthalmol Scand. 2003;81(6):583-7.
30. Altinors DD, Akca S, Akova YA, Bilezikçi B, Goto E, Dogru M, et al. Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol. 2006;141(6):1016-21.
31. Pryor WA. Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis. Br J Cancer Suppl. 1987;8:19-23.
32. Matsumoto Y, Dogru M, Goto E, Sasaki Y, Inoue H, Saito I, et al. Alterations of the tear film and ocular surface health in chronic smokers. Eye. 2008; 22(7):961-8.
33. Rummenie VT, Matsumoto Y, Dogru M, Wang Y, Hu Y, Ward SK, et al. Alterations of the tear film and ocular surface health in chronic smokers. Cytokine. 2008;43(2):200-8.
34. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002;506(Pt B):989-98.
35. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol. 1984;68(9):674-80.
36. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology. 1995;102(4):678-86.
37. Donato H, Jr., Hoselton MA, Sohal RS. Lipofuscin accumulation: effects of individual variation and selective mortality on population averages. Exp Gerontol. 1979;14(3):141-7.
38. Terman A, Brunk UT. Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev. 1998;104(3):277-91.
39. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. Faseb J. 2000;14(11):1490-8.
40. Spiteller G. Lipid peroxidation in aging and age-dependent diseases. Exp Geronto.l 2001;36(9):1425-57.
41. Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002;33(5):611-9.
42. th International Conference on the Tear Film and Ocular Surface. Taormina. Italy, September 4-9, 2007.